NKG2D/NKG2-Ligand Pathway Offers New Opportunities in Cancer TreatmentAlexandra Frazao, Anne Caignard, Louise Rethacker et al.|Frontiers in Immunology|2019Cited by 95
CD16+NKG2Ahigh Natural Killer Cells Infiltrate Breast Cancer–Draining Lymph NodesAlexandra Frazao, Anne Caignard, Eliane Piaggio et al.|Cancer Immunology Research|2018Cited by 65
Bystander hyperactivation of preimmune CD8+ T cells in chronic HCV patientsCécile Alanio, Matthew L. Albert, Francesco Nicoli et al.|eLife|2015Cited by 56
Prevalence of UBA1 mutations in MDS/CMML patients with systemic inflammatory and auto-immune diseaseLin‐Pierre Zhao, Lionel Adès, Bérénice Schell et al.|Leukemia|2021Cited by 43
Myelodysplastic Syndrome associated TET2 mutations affect NK cell function and genome methylationMaxime Boy, Nicolas Dulphy, Valéria Bisio et al.|Nature Communications|2023Cited by 39